SS Innovations International (SSII) Return on Invested Capital (2021 - 2026)
SS Innovations International recorded quarterly Return on Invested Capital of 0.0% in Q1 2026, up 23.37% quarter-over-quarter from 0.0% in Q4 2025.
SS Innovations International's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
- Return on Invested Capital came in at 0.0% for Q1 2026 at SS Innovations International, up from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q2 2022 to a low of 0.05% in Q1 2022.
- A 3-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Invested Capital.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.00% |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | 0.03% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | 0.45% |